AzTrials
AzTrials

Health Care Quality, Access, and EvaluationHMINCT02696174

Effectiveness of A Health Microinsurance Scheme for Private Primary Care in Malaysia

A study testing HMI in people with Health Care Quality, Access, and Evaluation and Insurance, Health, run by Chulalongkorn University.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

This is the Phase 3 of a 3 phase study to determine the feasibility, acceptability and effectiveness of a health microinsurance scheme in improving health equity and clinical outcomes for private primary care (PPC) in Kuala Lumpur, Malaysia. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
What is being tested?
HMI
Could I receive a placebo?
No, everyone receives an active treatment
How many people
114 participants
Where
No sites listed yet
Study dates
Apr 2016to Dec 2016
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Households were located in the study area
  • Method of payment to clinic is by out-of-pocket
  • This is household's regular choice of primary care provider.
  • Patient has been seen in the clinic since at least the past two years i.e from before Jan 1, 2014

Who cannot join

  • Households had members who died in the year 2014.
  • Households had members who were away from this place of residence for work/transferred for more than 1 month in 2014.
  • Households had members who had regular follow-up in public facilities for chronic disease.
  • Households with members who have switched methods of payment in the last year- (e.g newly bought insurance or retired and lost health benefits so paying OOP)
  • Patients who refuse consent

Trial locations and contacts

No sites are listed yet.

Dr Murallitharan Munisamy contact

+60123173575

murallimd@gmail.com

Dr Tharini Thanapalan contact

+60123550810

tharini29@gmail.com

About this study

Official title: Effectiveness of A Health Microinsurance Scheme in Improving Health Equity and Clinical Outcomes for Private Primary Care in Kuala Lumpur, Malaysia

This is the Phase 3 of a 3 phase study to determine the feasibility, acceptability and effectiveness of a health microinsurance scheme in improving health equity and clinical outcomes for private primary care (PPC) in Kuala Lumpur, Malaysia. This two-arm, pre-post, quasi-experimental trial consisted of utilizing a HMI scheme (experimental clinic) and normal OOP payments (control clinic) for 6 months. The HMI scheme enabled subscribed households to access a defined benefit package at a selected PPC for treatment and follow-up.

Read the detailed description

This will be a quasi-experimental study designed to determine the effectiveness of a community health microinsurance scheme (HMI) in private primary care clinics in Malaysia via a pre-post study of an experimental and control clinic. A proposed HMI scheme, whose price and benefit package have been defined through the earlier Phases 1 and 2, will be accessible to subscribed households at the experimental clinic, while the control clinic has subscribed patients paying as per normal practise, which is by Out-Of-Pocket payment. The HMI scheme enabled subscribers to visit the selected clinic chosen for any form of primary care diagnosis, treatment and follow-up. Both the clinics are located in the Jalan Ipoh area, a suburb of Kuala Lumpur, and have common sociodemographic characteristics. A pre-intervention questionnaire will aim to capture health seeking behaviour, delay in seeking medical care, monthly health expenditure and improvements in clinical outcome (assessed by clinical test results). After six months, a post-intervention questionnaire is administered again to the respondents which then allows assessment of the outcome variables.

Being tested
HMI

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • HMIOther

    Also called Health Microinsurance Scheme

    A defined priced package of primary care services, including investigation and treatment such as procedures and medication, available at a selected clinic for 6 months

Study groups in NCT02696174
Study groupRoleWhat they receive
Health Microinsurance SchemeExperimentalHouseholds owning the HMI package, entitling them to visit and receive treatment from the selected primary care clinic
Receives: Other: HMI
Out-Of-PocketNo interventionHouseholds who visit the selected primary care clinic, but pay by Out-Of-Pocket

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Health-seeking behavior

    Delays in seeking healthcare (days)

    Measured: Change from Baseline health seeking behavior at 6 months

  2. Monthly health expenditure

    How much has been spent for monthly health expenses (in Ringgit Malaysia)

    Measured: Change from Baseline Monthly Health Expenditure at 6 months

Secondary outcomes (4)
  1. Clinical Outcome of Diabetes Mellitus

    Measurement of HbA1c

    Measured: Change from Baseline HbA1c at 6 months

  2. Clinical Outcome of Hypertension

    Resting mean blood pressure

    Measured: Change from Baseline Resting Mean Blood Pressure at 6 months

  3. Clinical outcome of dyslipidemia

    Total serum cholesterol and LDL

    Measured: Change from Baseline serum cholesterol and LDL at 6 months

  4. Clinical outcome of bronchial Asthma

    Spirometry levels

    Measured: Change from Baseline spirometry levels at 6 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted2 Mar 2016 (estimated)
  2. Study startApr 2016
  3. Primary completionSep 2016 (estimated)
  4. Study completionDec 2016 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Health services research
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
114 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02696174
Sponsor's protocol ID
NMRR 29311
Acronym
HMI
Status last verified
Mar 2016
First submitted
22 Feb 2016
Last updated
10 Mar 2016
Results posted
No
Data monitoring committee
Yes
Individual data sharing
Yes

Questions about this trial

What is this clinical trial studying?

A study testing HMI in people with Health Care Quality, Access, and Evaluation and Insurance, Health, run by Chulalongkorn University.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 10 Mar 2016. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Dr Murallitharan Munisamy (+60123173575, murallimd@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Health-seeking behavior (time frame: Change from Baseline health seeking behavior at 6 months). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 10 Mar 2016.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in